130 related articles for article (PubMed ID: 6171495)
1. alpha-1-Antitrypsin phenotypes in hepatocellular carcinoma.
Govindarajan S; Ashcavai M; Peters RL
Hepatology; 1981; 1(6):628-31. PubMed ID: 6171495
[TBL] [Abstract][Full Text] [Related]
2. Alpha-1-antitrypsin deficiency and hepatocellular carcinoma. Determination of Pi phenotypes using iso-electric focusing.
Vergalla J; Jones EA; Kew MC
S Afr Med J; 1983 Dec; 64(24):950-1. PubMed ID: 6316569
[TBL] [Abstract][Full Text] [Related]
3. Lack of increase in heterozygous alpha 1-antitrypsin deficiency phenotypes among patients with hepatocellular and bile duct carcinoma.
Rabinovitz M; Gavaler JS; Kelly RH; Prieto M; Van Thiel DH
Hepatology; 1992 Mar; 15(3):407-10. PubMed ID: 1312055
[TBL] [Abstract][Full Text] [Related]
4. Alpha 1-antitrypsin phenotypes in cirrhosis and hepatoma.
Theodoropoulos G; Fertakis A; Archimandritis A; Kapordelis C; Angelopoulos B
Acta Hepatogastroenterol (Stuttg); 1976 Apr; 23(2):114-7. PubMed ID: 179260
[TBL] [Abstract][Full Text] [Related]
5. Diffuse hepatocellular dysplasia and carcinoma associated with the Mmalton variant of alpha 1-antitrypsin.
Reid CL; Wiener GJ; Cox DW; Richter JE; Geisinger KR
Gastroenterology; 1987 Jul; 93(1):181-7. PubMed ID: 3034714
[TBL] [Abstract][Full Text] [Related]
6. Alpha-1 Antitrypsin and Hepatocellular Carcinoma in Liver Cirrhosis:
Rabekova Z; Frankova S; Jirsa M; Neroldova M; Lunova M; Fabian O; Kveton M; Varys D; Chmelova K; Adamkova V; Hubacek JA; Spicak J; Merta D; Sperl J
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638908
[TBL] [Abstract][Full Text] [Related]
7. Alpha 1-antitrypsin in patients with hepatocellular carcinoma and chronic active hepatitis.
Fargion S; Klasen EC; Lalatta F; Sangalli G; Tommasini M; Fiorelli G
Clin Genet; 1981 Feb; 19(2):134-9. PubMed ID: 6258829
[TBL] [Abstract][Full Text] [Related]
8. Alpha 1-antitrypsin levels and phenotypes and hepatitis B serology in liver cancer.
Sparos L; Tountas Y; Chapuis-Cellier C; Theodoropoulos G; Trichopoulos D
Br J Cancer; 1984 May; 49(5):567-70. PubMed ID: 6326791
[TBL] [Abstract][Full Text] [Related]
9. Tobacco smoking and other factors in relation to serum alpha-1-antitrypsin.
Petridou E; Chapuis-Cellier C; Roukas K; Lan SJ; Tzonou A; Trichopoulos D
Hum Biol; 1993 Jun; 65(3):425-32. PubMed ID: 7686528
[TBL] [Abstract][Full Text] [Related]
10. Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi∗Z Variant of AAT (Pi∗MZ vs Pi∗ZZ genotype) and Noncarriers.
Schneider CV; Hamesch K; Gross A; Mandorfer M; Moeller LS; Pereira V; Pons M; Kuca P; Reichert MC; Benini F; Burbaum B; Voss J; Gutberlet M; Woditsch V; Lindhauer C; Fromme M; Kümpers J; Bewersdorf L; Schaefer B; Eslam M; Bals R; Janciauskiene S; Carvão J; Neureiter D; Zhou B; Wöran K; Bantel H; Geier A; Dirrichs T; Stickel F; Teumer A; Verbeek J; Nevens F; Govaere O; Krawczyk M; Roskams T; Haybaeck J; Lurje G; Chorostowska-Wynimko J; Genesca J; Reiberger T; Lammert F; Krag A; George J; Anstee QM; Trauner M; Datz C; Gaisa NT; Denk H; Trautwein C; Aigner E; Strnad P;
Gastroenterology; 2020 Aug; 159(2):534-548.e11. PubMed ID: 32376409
[TBL] [Abstract][Full Text] [Related]
11. Cirrhosis and hepatocellular carcinoma in a patient with heterozygous (MZ) alpha-1-antitrypsin deficiency.
Marwick TH; Cooney PT; Kerlin P
Pathology; 1985 Oct; 17(4):649-52. PubMed ID: 3005953
[TBL] [Abstract][Full Text] [Related]
12. An association between alpha 1-antitrypsin phenotype and chronic liver disease.
Kishimoto Y; Yamada S; Hirayama C
Hum Genet; 1990 Jan; 84(2):132-6. PubMed ID: 2153626
[TBL] [Abstract][Full Text] [Related]
13. Is there a relationship between alpha-1-antitrypsin Pi MZ phenotype and hepatoma?
Charlionet R; Martin JP; Sesboué R; Ropartz C
Biomedicine; 1976 Jun; 25(4):125-6. PubMed ID: 60146
[No Abstract] [Full Text] [Related]
14. alpha 1-antitrypsin phenotype PiMZ, a risk factor for liver cirrhosis but not for liver cancers in Thailand.
Smanadhikorn P; Pongpaew P; Srivatanakul P; Tungtrongchitr R; Supanaranond W; Schelp FP; Migasena P
Southeast Asian J Trop Med Public Health; 1995 Jun; 26(2):240-2. PubMed ID: 8629052
[TBL] [Abstract][Full Text] [Related]
15. Alpha-1-antitrypsin deficiency and liver diseases in Nigeria.
Olusi SO
Trop Geogr Med; 1990 Jan; 42(1):41-6. PubMed ID: 2175465
[TBL] [Abstract][Full Text] [Related]
16. Alpha-1-antitrypsin phenotypes in adult liver disease patients.
Topic A; Alempijevic T; Milutinovic AS; Kovacevic N
Ups J Med Sci; 2009; 114(4):228-34. PubMed ID: 19961268
[TBL] [Abstract][Full Text] [Related]
17. [Nonspecific tumor markers in hepatocellular carcinoma].
Stanciu L; Dumitraşcu D; Radu D; Badea R; Petcovici M; Ioniţă A; Szabo P; Pascu O
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(5):443-9. PubMed ID: 2473509
[No Abstract] [Full Text] [Related]
18. Alpha-1-antitrypsin MZ phenotype and cryptogenic chronic liver disease in adults.
Vecchio FM; Fabiano A; Orsini G; Ragusa D; Massi G
Digestion; 1983; 27(2):100-4. PubMed ID: 6354808
[TBL] [Abstract][Full Text] [Related]
19. Distribution of five antigens in hepatocellular carcinoma.
Thung SN; Gerber MA; Sarno E; Popper H
Lab Invest; 1979 Aug; 41(2):101-5. PubMed ID: 88543
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma in a patient with sarcoidosis-associated chronic active hepatitis and the MZ alpha-1-antitrypsin phenotype.
Kronborg IJ; Bhathal PS; Mackay IR; Storey E; Long TM
Liver; 1983 Apr; 3(2):92-9. PubMed ID: 6308380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
